Chief Medical Officer Stephen Brannan Sells 5,000 Shares of Karuna Therapeutics Inc (KRTX)

Karuna Therapeutics Inc (NASDAQ:KRTX), a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric disorders, has reported an insider sale according to a recent SEC filing.

Related Keywords

,Karuna Therapeutics Inc ,Stephen Brannan ,Iopharmaceutical Company ,Insider Trading ,Therapeutics Inc ,Chief Medical Officer ,Fec Filing ,Neuropsychiatric Disorders ,Securities Exchange Commission ,